Clinical Trial

Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)

Name: Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH) — clinical trial record (NCT07441200)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Trial to Evaluate the Efficacy and Safety of Orally Administered NS-863 in Participants with Pulmonary Arterial Hypertension (PAH)

Trial Details

NCT Number	NCT07441200
Lead Sponsor	NS Pharma, Inc. Collaborators: Nippon Shinyaku Co., Ltd.
Conditions	Pulmonary Arterial Hypertension
Enrollment	135 participants
Start Date	2026-07-01
Primary Completion	2028-08-01 (estimated)
Study Completion	2028-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-27